ES538721A0 - Un procedimiento para preparar derivados de guanina - Google Patents

Un procedimiento para preparar derivados de guanina

Info

Publication number
ES538721A0
ES538721A0 ES538721A ES538721A ES538721A0 ES 538721 A0 ES538721 A0 ES 538721A0 ES 538721 A ES538721 A ES 538721A ES 538721 A ES538721 A ES 538721A ES 538721 A0 ES538721 A0 ES 538721A0
Authority
ES
Spain
Prior art keywords
guanina
derivatives
preparing
procedure
preparing guanina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES538721A
Other languages
English (en)
Other versions
ES8609325A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8307051A external-priority patent/SE8307051D0/xx
Priority claimed from SE8307052A external-priority patent/SE8307052D0/xx
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of ES8609325A1 publication Critical patent/ES8609325A1/es
Publication of ES538721A0 publication Critical patent/ES538721A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1745—Unsaturated ethers containing halogen containing six-membered aromatic rings having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1787—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings and having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
ES538721A 1983-12-20 1984-12-18 Un procedimiento para preparar derivados de guanina Expired ES8609325A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8307051A SE8307051D0 (sv) 1983-12-20 1983-12-20 Novel derivatives of alkyl guanine novel derivatives of alkyl guanine
SE8307052A SE8307052D0 (sv) 1983-12-20 1983-12-20 Novel derivatives of guanine novel derivatives of guanine

Publications (2)

Publication Number Publication Date
ES8609325A1 ES8609325A1 (es) 1986-09-01
ES538721A0 true ES538721A0 (es) 1986-09-01

Family

ID=26658599

Family Applications (3)

Application Number Title Priority Date Filing Date
ES538721A Expired ES8609325A1 (es) 1983-12-20 1984-12-18 Un procedimiento para preparar derivados de guanina
ES546916A Expired ES8704170A1 (es) 1983-12-20 1985-09-12 Un procedimiento para preparar derivados de guanina
ES554546A Expired ES8800946A1 (es) 1983-12-20 1986-04-30 Un procedimiento para preparar derivados de guanina

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES546916A Expired ES8704170A1 (es) 1983-12-20 1985-09-12 Un procedimiento para preparar derivados de guanina
ES554546A Expired ES8800946A1 (es) 1983-12-20 1986-04-30 Un procedimiento para preparar derivados de guanina

Country Status (20)

Country Link
US (1) US4798833A (es)
EP (2) EP0146516A3 (es)
JP (1) JPH0667939B2 (es)
KR (1) KR910010048B1 (es)
AU (1) AU586415B2 (es)
CA (1) CA1285560C (es)
DE (1) DE3477568D1 (es)
DK (1) DK159683C (es)
ES (3) ES8609325A1 (es)
FI (1) FI80885C (es)
GB (1) GB2151622B (es)
GR (1) GR82499B (es)
HU (1) HU193595B (es)
IE (1) IE57913B1 (es)
IL (1) IL73682A (es)
IS (1) IS1507B (es)
MY (1) MY102565A (es)
PH (1) PH21410A (es)
PT (1) PT79714B (es)
WO (1) WO1985002845A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684153A (en) 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
CA1288098C (en) * 1984-08-24 1991-08-27 Richard L. Tolman 4-(guanin-9-yl)butanals and their 3-oxa, 3-thia and 2-ene derivatives having antiviral and antitumor activity
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
EP0216459B1 (en) * 1985-07-27 1990-05-16 Beecham Group Plc 9-substituted guanine monohydrates
EP0219838A3 (en) * 1985-10-22 1988-04-06 Takeda Chemical Industries, Ltd. Carbocyclic purine nucleosides, their production and use
US5066655A (en) * 1987-04-24 1991-11-19 Whitby Research, Inc. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5175288A (en) * 1987-08-01 1992-12-29 Beecham Group P.L.C. Process for preparing purine derivatives and intermediates thereof
US4935427A (en) * 1987-12-31 1990-06-19 The United States Of America As Represented By The Department Of Health And Human Services Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents
SE8801729D0 (sv) * 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
US5284837A (en) * 1988-05-06 1994-02-08 Medivir Ab Derivatives of purine, process for their preparation and a pharmaceutical preparation
GB8817607D0 (en) * 1988-07-23 1988-09-01 Beecham Group Plc Novel process
GB8822236D0 (en) * 1988-09-21 1988-10-26 Beecham Group Plc Chemical process
CA2009109A1 (en) * 1989-02-02 1990-08-02 John Hannah Antiviral acyclonucleosides and acyclonucleotides
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
GB8922076D0 (en) * 1989-09-28 1989-11-15 Beecham Group Plc Novel process
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
US5674869A (en) * 1990-07-07 1997-10-07 Beecham Group Plc Pharmaceutical treatment
WO1995000515A1 (en) * 1993-06-23 1995-01-05 Merrell Pharmaceuticals Inc. Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
AT412211B (de) * 1996-07-20 2004-11-25 Novartis Int Pharm Ltd Verfahren zur herstellung von penciclovir und famciclovir
GB9615276D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
GB9615253D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
GB9807114D0 (en) 1998-04-02 1998-06-03 Smithkline Beecham Plc Novel process
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
DE3278501D1 (en) * 1981-08-11 1988-06-23 Wellcome Found Antiviral compounds
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
EP0216459B1 (en) * 1985-07-27 1990-05-16 Beecham Group Plc 9-substituted guanine monohydrates

Also Published As

Publication number Publication date
DE3477568D1 (en) 1989-05-11
US4798833A (en) 1989-01-17
IL73682A (en) 1991-08-16
PH21410A (en) 1987-10-15
ES8609325A1 (es) 1986-09-01
KR910010048B1 (ko) 1991-12-12
EP0165289B1 (en) 1989-04-05
FI853171A0 (fi) 1985-08-19
EP0146516A2 (en) 1985-06-26
DK362585D0 (da) 1985-08-09
FI853171L (fi) 1985-08-19
FI80885C (fi) 1990-08-10
GB8431910D0 (en) 1985-01-30
IS1507B (is) 1992-09-29
GB2151622A (en) 1985-07-24
GB2151622B (en) 1988-05-11
ES554546A0 (es) 1987-12-01
FI80885B (fi) 1990-04-30
IE843261L (en) 1985-06-20
PT79714B (en) 1986-12-30
ES8704170A1 (es) 1987-03-16
JPH0667939B2 (ja) 1994-08-31
JPS61500730A (ja) 1986-04-17
EP0146516A3 (en) 1985-08-14
CA1285560C (en) 1991-07-02
AU586415B2 (en) 1989-07-13
IS2966A7 (is) 1985-06-21
IE57913B1 (en) 1993-05-19
DK159683B (da) 1990-11-19
ES8800946A1 (es) 1987-12-01
AU3787385A (en) 1985-07-12
MY102565A (en) 1992-07-31
KR850700136A (ko) 1985-10-25
DK362585A (da) 1985-08-09
HU193595B (en) 1987-11-30
PT79714A (en) 1985-01-01
EP0165289A1 (en) 1985-12-27
IL73682A0 (en) 1985-02-28
GR82499B (en) 1985-04-19
DK159683C (da) 1991-04-15
WO1985002845A1 (en) 1985-07-04
ES546916A0 (es) 1987-03-16
HUT37619A (en) 1986-01-23

Similar Documents

Publication Publication Date Title
ES546916A0 (es) Un procedimiento para preparar derivados de guanina
ES539563A0 (es) Un procedimiento para preparar derivados de fenilamino-mer- captoimidazol
ES547903A0 (es) Un procedimiento para preparar derivados de fluoro-fenoxife-nilo
ES530916A0 (es) Un procedimiento para preparar derivados de pirimidina
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES534694A0 (es) Un procedimiento para preparar cefuroxima sodica
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES545347A0 (es) Un procedimiento para preparar derivados de pirimidina
ES533842A0 (es) Un procedimiento para la obtencion de derivados de amino-pirimidina
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES528003A0 (es) Un procedimiento para preparar derivados de cefem
ES548409A0 (es) Un procedimiento para preparar derivados de bencimidazol
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES547419A0 (es) Un procedimiento para preparar derivados de pirimidina
ES536050A0 (es) Un procedimiento para preparar fenil-carbamatos sustituidos
ES534170A0 (es) Un procedimiento para preparar 1-piridil-alquil-4-aril-piperazinas
ES552911A0 (es) Un procedimiento para preparar derivados de 3-carbonil-1-aminoalquil-1h-indol
ES538072A0 (es) Un procedimiento para preparar un difenil-eter
ES531851A0 (es) Un procedimiento para preparar derivados de morfolina
ES536293A0 (es) Un procedimiento para producir derivados de acilindol
ES546690A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indoldiona
ES547458A0 (es) Un procedimiento para preparar derivados de piridiloxi
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060529